NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer

CompletedNA

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions: Breast Screening

Interventions: Clinical Breast exam (CBE), iBreastExam device, mammogram

Countries: United States

This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination. The iBreastExam is a handheld device that performs a painless electronic palpation (examination by touch) of the breast. The device is designed to detect breast abnormalities that may require breast imaging and additional clinical examination by a nurse or doctor. The iBreastExam device creates a color map of the breast, with red spots indicating areas that may be abnormal.

Eligibility overview

Sex: FEMALE

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Female patient
* Over 18 years of age, able to consent
* RLC patients presenting to RLC or BAIC for mammogram and CBE
* Asymptomatic and symptomatic patients will be included

Exclusion Criteria:

* Male patients
* Patients under 18 years of age, unable to consent
* Pregnant patients
* Lactating patients
* Non-intact skin

Locations (2)

New York, New York, United States
New York, New York, United States